-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
6.
726 billion yuan, an increase of 45.
08% year-on-year, and the net profit attributable to shareholders of listed companies increased by 133.
74% year-on-year
.
While the outside world is focusing on Yuyue Medical’s high performance growth, its clear development direction is rarely interpreted
Macro-trends established corporate strength support
The aging trend is accelerating, the base of patients with chronic diseases has expanded, and users' awareness of home monitoring has reached a preliminary stage of maturity after years of market education.
These have laid a firm foundation for the continuous expansion of the chronic disease monitoring market
.
This also explains why, despite the overall weakness of the e-commerce market under the impact of the 2020 epidemic, Yuyue Medical’s online business has grown by 30% against the trend
.
In addition, there are also electronic sphygmomanometers with a growth rate of over 35% and blood glucose meters and test strips with a growth rate of over 30%
Looking through these growth data, it can be found that the more mature the technology is, the more Chinese brands represented by Yuyue Medical will become the first choice of the people.
Coupled with the macro-market catalysis, sustained growth has long been traced
.
In fact, Yuyue Medical’s products such as oxygen respiration and chronic disease monitoring have covered the current high-incidence and typical needs of chronic disease patients
.
Once the user habit is formed, it will extend the use of all types of products from a single product, and Yuyue Medical’s data strategy has already achieved results, which will increase user stickiness
Whether it is the substantial growth of sub-categories or the online growth that reflects the relationship between products and consumers, it fully demonstrates Yuyue Medical's strong strength and distinct advantages based on product strength, brand power, and user base
.
Closer inside and outside the hospital, sufficient cash flow is the trump card
2020 is a crucial year in the history of Yuyue Medical's development.
If there is no solid accumulation and advanced layout in the first 20 years, it will be difficult to show such a strong explosive force
.
This year also demonstrated the "close correlation between the hospital and the hospital" of Yuyue Medical in the three major sections of respiration, blood sugar, and sensory control and disinfection
To be sure, Yuyue Medical has already occupied a solid and unshakable position in the above three sectors.
With the focus of R&D, market, and investment, there is still sufficient growth potential to be released
.
Strategic focus requires investment in resources.
Based on this, Yuyue Medical's cash flow of 2.
831 billion yuan firstly provides a strong guarantee for R&D, lean manufacturing, and overseas deployment
.
In particular, medical research and development requires years of deep cultivation, huge investment, mergers and acquisitions, and even a "marathon" investment that bears trial and error costs.
Sufficient cash flow is undoubtedly an important engine
.
In 2020, Yuyue Medical's investment based on R&D has exceeded 70% year-on-year.
Since the release of the annual report, Huatai Securities, Ping An Securities, and Soochow Securities have all given “strong recommendation” and “buy” ratings, all of which have given Yuyue Medical’s product competitiveness, brand influence, market potential, etc.
